Hyo-Min Park

5PUBLICATIONS
9CO-AUTHORS
Tumour immunologyHaematological tumoursMedical mycologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 08, 2024
Recombinant Human IL-32θ Induces Polarization Into M1-like Macrophage in Human Monocytic Cells.

Hyo-Min Park, Jae-Young Park, Na-Yeon Kim

|Sep 02, 2023
Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells.

Hyo-Min Park, Jae-Young Park, Na-Yeon Kim

|Apr 28, 2023
MMPP Exerts Anti-Inflammatory Effects by Suppressing MD2-Dependent NF-κB and JNK/AP-1 Pathways in THP-1 Monocytes.

Seonhwa Kim, Na-Yeon Kim, Jae-Young Park

|Jun 02, 2021
Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells.

Thu-Huyen Pham, Hyo-Min Park, Jinju Kim

|Dec 29, 2020
STAT3 and p53: Dual Target for Cancer Therapy.

Thu-Huyen Pham, Hyo-Min Park, Jinju Kim

Pageof 1